Zobrazeno 1 - 10
of 673
pro vyhledávání: '"Kevin A. Coleman"'
Autor:
Asli Muvaffak, Kevin G. Coleman
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundAtaxia telangiectasia-mutated (ATM) kinase is a central regulator of the DNA damage response (DDR) signaling pathway, and its function is critical for the maintenance of genomic stability in cells that coordinate a network of cellular proce
Externí odkaz:
https://doaj.org/article/25bed31213ed4a50acfbdf2081992ecd
Autor:
Mento, Joan
Publikováno v:
Shakespeare Bulletin, 2001 Oct 01. 19(4), 21-22.
Externí odkaz:
https://www.jstor.org/stable/26355663
Autor:
Mento, Joan
Publikováno v:
Shakespeare Bulletin, 2000 Oct 01. 18(4), 25-26.
Externí odkaz:
https://www.jstor.org/stable/26355893
Autor:
Mento, Joan
Publikováno v:
Shakespeare Bulletin, 1995 Oct 01. 13(4), 18-19.
Externí odkaz:
https://www.jstor.org/stable/26352876
Autor:
Coursen, H. R.
Publikováno v:
Shakespeare Bulletin, 1994 Apr 01. 12(2), 16-17.
Externí odkaz:
https://www.jstor.org/stable/26352159
Autor:
Karen A. Simon-Crevatis, Shailesh R. Metkar, Justin T. Hardcastle, Keith Jansson, Usman Shabon, Rajarshi Choudhury, Euan A. Stronach, Kevin G. Coleman, Asli Muvaffak
Publikováno v:
Cancer Research. 83:6175-6175
While cyclin dependent kinases (CDKs) were originally implicated in cell cycle regulation, several CDKs including CDK7, CDK8, and CDK9 play critical roles in transcription through regulation of RNA polymerase II (Pol II) activity. In addition to expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e5a84d1ec42e305a931c904608fbcac
https://doi.org/10.1158/1538-7445.am2023-6175
https://doi.org/10.1158/1538-7445.am2023-6175
Publikováno v:
In Additives for Polymers 2000 2000(10):16-16
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e28022 (2011)
Although G-protein coupled receptors (GPCRs) are a common element in many chemosensory transduction pathways in eukaryotic cells, no GPCR or regulated G-protein activity has yet been shown in any ciliate. To study the possible role for a GPCR in the
Externí odkaz:
https://doaj.org/article/95d378cfa44f4b8786aa80071bbb1727
Autor:
Asli Muvaffak, Kevin G. Coleman
Publikováno v:
Cancer Research. 80:2379-2379
PARP inhibitors have transformed the treatment for ovarian cancer, which is known to have high incidence of homologous recombination (HR) deficiency through the loss of BRCA1 or BRCA2 genes. 30-35% of ovarian cancer patients have defects in BRCA1/2 g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59e05a63b3d18ba5e8e8b14ae86e00d6
https://doi.org/10.1158/1538-7445.am2020-2379
https://doi.org/10.1158/1538-7445.am2020-2379